TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LTC

LTC Properties Inc

Real Estate · REIT - Healthcare Facilities

42.60$ -2.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios LTC
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
21.6 22.0 21.3 19.8 10.7 22.1 16.0 23.9 14.2 14.8 16.8 13.6
13.3 11.8 11.2 10.3 9.9 9.6 9.6 8.6 8.1 6.7 7.3 6.1
2.4 2.4 2.5 2.3 2.0 2.3 2.0 1.8 1.7 1.5 1.6 1.5
17.8 18.3 17.4 17.0 16.2 16.1 16.6 16.5 12.7 12.7 10.5 8.5
18.9 20.8 19.1 18.5 12.2 19.8 16.0 21.0 13.1 14.2 12.9 11.3
16.8 15.8 17.4 16.6 14.5 14.6 13.2 14.6 13.5 12.7 12.2 11.8
6.0% 6.3% 5.7% 6.0% 6.9% 6.8% 7.6% 6.8% 7.4% 7.9% 8.2% 8.5%
Margins
89.0% 87.2% 83.6% 100.0% 100.0% 91.0% 90.5% 90.1% 91.2% 93.3% 93.8% 75.1%
57.5% 51.9% 52.0% 50.6% 90.3% 44.2% 60.0% 35.3% 56.6% 45.6% 44.0% 48.2%
61.7% 53.7% 52.7% 52.0% 91.9% 43.5% 59.8% 36.0% 57.1% 45.5% 43.4% 44.9%
79.2% 74.5% 64.5% 62.1% 67.8% 65.8% 72.6% 58.7% 60.3% 52.9% 59.6% 51.7%
Returns
11.1% 11.1% 11.5% 11.5% 18.6% 10.3% 12.3% 7.5% 12.1% 10.2% 9.5% 11.0%
7.6% 5.7% 6.1% 6.0% 10.2% 5.3% 6.5% 3.7% 6.0% 4.8% 5.1% 5.7%
Balance Sheet & Debt
538 890 997 1,137 1,063 1,195 1,111 1,230 807 1,173 675 626
4.8 7.4 6.8 7.3 4.8 7.9 6.8 10.1 4.8 6.7 3.9 3.2
68.3% 51.7% 53.1% 51.8% 55.0% 51.9% 53.2% 49.5% 50.0% 47.5% 53.8% 52.1%
0.9 1.4 1.4 1.5 1.3 1.5 1.4 1.7 1.0 1.4 0.7 0.6
Per Share
2.00 1.96 2.21 2.20 3.89 2.03 2.43 1.43 2.50 2.17 2.06 2.53
3.25 3.65 4.19 4.24 4.23 4.66 4.06 3.97 4.37 4.77 4.74 5.65
18.02 17.66 19.17 19.14 20.91 19.75 19.76 19.03 20.67 21.31 21.71 23.09
2.57 2.72 2.70 2.63 2.87 3.06 2.95 2.33 2.64 2.52 2.83 2.92

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?